Adults with inflammatory bowel disease produced strong antibody responses to messenger RNA COVID-19 vaccines, according to findings published in Annals of Internal Medicine.

Researchers said the findings may “reassure” patients receiving immunosuppressive therapy for inflammatory bowel disease (IBD) that “initial humoral responses to mRNA vaccines are generally robust.”

“For some, like organ transplant recipients and people undergoing chemotherapy, there is a significant portion of immunocompromised patients who do not respond to vaccination, and those patients

Full Article: